Alantos Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in Cambridge, MA and active since 2007.
Alantos Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Keith E Dionne at the company’s headquarters by writing to 840 Memorial Drive Floor 2, Cambridge, Massachusetts MA 02139 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alantos Pharmaceuticals Inc |
| Contact Person: | Keith E Dionne |
| Address: | 840 Memorial Drive Floor 2, Cambridge, Massachusetts 02139 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2007 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Alantos Pharmaceuticals Inc was started in 2007 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Keith E Dionne for inquiries that concern Alantos Pharmaceuticals Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Alantos Pharmaceuticals Inc can be found at the coordinates 42.36283,-71.115879 as well as the street address 840 Memorial Drive Floor 2 in Cambridge, Massachusetts 02139.
For its online presence, you may visit Alantos Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.